GLP-1 receptor agonists (GLP-1 RAs) have changed the conversation around Type 2 diabetes and weight management. These injectable medications not only lower blood sugar, but they also reduce appetite, support weight loss, and have a positive impact on heart health.…
A recent study from Virginia Tech analyzed how GLP-1 medications such as Ozempic, Wegovy, and Mounjaro affect alcohol absorption and perceived intoxication. Researchers measured breath alcohol levels and self-reported intoxication in adults with obesity, comparing participants taking GLP-1 drugs with…
For decades, artificial sweeteners have lived under the shadow of controversy. They have been accused of confusing the body, harming the gut, and even encouraging overeating. Headlines and social media have fueled this narrative, often without the depth of evidence…
In a major step forward for people with type 2 diabetes, MedPage Today reports that the FDA has approved oral semaglutide (Rybelsus) to prevent major adverse cardiovascular events (MACE) in high-risk adults — whether or not they’ve had such an event already. That means…
For months, the national conversation around GLP-1 drugs has focused on one question: can anyone afford to stay on them long enough to see results? It’s a valid concern. Medications like semaglutide and tirzepatide have transformed obesity care, but their…
A new study has given researchers a clearer picture of why popular GLP-1 weight-loss drugs like Ozempic and Zepbound appear to curb alcohol cravings. Published in Scientific Reports, the pilot study found that these medications may slow the speed at which…
For years, Body Mass Index (BMI) has been treated as the universal measure of health. A simple calculation that places people into neat categories of “normal,” “overweight,” or “obese.” But a new study published in JAMA Network Open suggests that this…
GLP-1 medications have quickly become a cornerstone of modern weight management, reshaping how patients and clinicians approach obesity, diabetes, and metabolic health. These drugs—marketed under names like Ozempic, Wegovy, Zepbound, and Mounjaro—work by mimicking natural hormones that regulate appetite and blood…
When Novo Nordisk announced that Ozempic and Wegovy would now be available at Costco pharmacies for $499 per month, it marked an important step in expanding access to one of the most significant medical breakthroughs in modern weight management. The move means that people without…
There’s a phrase we’ve all heard before: “I’ll start after the holidays.” It sounds reasonable. After all, the next few months are packed with parties, travel, and never-ending to-do lists. But here’s the truth: if you wait until January to focus…